141396-28-3CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1.OAIEZTKLTLCMZIA-WOXJCXRUNA-NSee also: Argatroban (annotation moved to).
This chemical does not meet GHS hazard criteria for 50% (2 of 4) of reports.
Danger
H223 (25%): Flammable aerosol [Warning Aerosols]
P210, P211, P251, P261, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P317, P321, P337+P317, P362+P364, P410+P412, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
使用Argatroban monohydrate has been used as a thrombin-selective inhibitor in the thrombin assay of platelet poor plasma samples. It may be used as a standard in gradient reversed-phase liquid chromatography coupled with high-resolution multistage mass spectrometry (LC/HR-MSn) for photoproducts fragmentation analysis and as a thrombin inhibitor competitive assay with fullerene-based C60 nanoparticle (NPs).
一般的な説明Argatroban anticoagulant is synthesized from L-arginine and photodegrades under light exposure.
読み込み中…
141396-28-3